Latest China News

Ariana Resources has sold its remaining 9.9% stake in the Kiziltepe mine for US$3.7 million, boosting cash reserves to A$39 million and sharpening focus on its flagship 1.6Moz Dokwe Gold Project in Zimbabwe.

Arafura Rare Earths has taken a decisive step forward on its Nolans Project, announcing a Final Investment Decision and securing over A$700 million in cash and term deposits as it prepares to start construction in September 2026.

Meteoric Resources has completed a Definitive Feasibility Study for its Caldeira Rare Earth Project in Brazil, revealing a large, high-grade ionic clay deposit with a 20-plus year mine life and strong financial metrics.

Jindalee Lithium is pushing ahead with its McDermitt Lithium Project in the US, securing shareholder approval for a NASDAQ listing via US Elemental and raising $10.9 million to fund drilling and testwork. The project aims to deliver both lithium and magnesium, aligning with US critical minerals priorities.

Godolphin Resources has unveiled a significant polymetallic sulphide discovery at Cousin Jack within its Lewis Ponds Project, alongside progressing an IPO to spin out its Narraburra Rare Earths asset into Matrix Critical Minerals.

Talga Group has marked a milestone with its first commercial delivery of natural graphite anode outside Asia, progressing key funding discussions and strategic partnerships to support its Vittangi Anode Project.

Actinogen Medical’s pivotal XanaMIA Alzheimer’s trial stays on track for November topline results, buoyed by strong open-label extension enrolment and aligned EMA-FDA regulatory advice. A new antidepressant study publication and fresh patents add momentum, supported by a $16.7 million cash runway to mid-2027.

Firebird Metals has secured a Perth site and placed all major equipment orders for its Australian Demonstration Plant, backed by a A$2 million ARENA grant. Independent testing confirms ultra-high purity manganese sulphate production, reinforcing its technology's potential.

NOVONIX has hit a critical milestone by delivering a synthetic graphite anode sample to Panasonic, supporting a planned production start in late 2027. The company secured A$21.66 million in fresh capital to fund production readiness, while navigating an evolving US trade and policy landscape aimed at boosting domestic battery materials.

Dimerix Limited (ASX: DXB) has inked its fifth regional licensing agreement with Everest Medicines, boosting potential milestone payments to A$1.9 billion and expanded its kidney disease pipeline through the acquisition of DMX-652. The Phase 3 ACTION3 trial for DMX-200 remains statistically robust, with funding secured to advance both clinical programs.

Right Resources’ latest quarter reveals a promising new Reduced Intrusion-Related Gold System and high-grade tungsten discoveries at Tumbarumba, backed by a $2.7 million capital raise.

Xenitra Limited (ASX:XEN) has turned around its cash flow in Q4 FY26, reporting positive operating cash flow of A$0.8 million driven by a leaner cost base and a shift towards higher-margin OTC medicines and blockchain-enabled OPAL tokenised sales.